Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population‐Based Case–Control Study
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.71110
Abstract: Glucocorticoids may promote prostate cancer by reducing apoptosis and the immune response, or prevent it by reducing inflammation, inhibiting androgens, and limiting cell proliferation. However, epidemiological evidence is limited. Thus, this study aimed to assess… read more here.
Keywords: use systemic; glucocorticoids risk; systemic glucocorticoids; evidence ... See more keywords
Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14283
Abstract: Essentials The risk of thrombosis among ischemic stroke patients using glucocorticoids is unknown. We examined the risk of thrombosis in 98 487 ischemic stroke patients, by glucocorticoid use. Myocardial infarction and venous thromboembolism risk was… read more here.
Keywords: risk; ischemic stroke; use glucocorticoids; preadmission use ... See more keywords
Glucocorticoids as a risk factor for infection and adverse outcomes in non‐HIV and non‐transplant patients with cryptococcal meningitis
Sign Up to like & getrecommendations! Published in 2024 at "Mycoses"
DOI: 10.1111/myc.13709
Abstract: Cryptococcal meningitis (CM), an opportunistic fungal infection affecting immunocompromised hosts, leads to high mortality. The role of previous exposure to glucocorticoids as a risk factor and as an outcome modulator has been observed, but systematic… read more here.
Keywords: glucocorticoids risk; cryptococcal meningitis; risk factor; infection ... See more keywords